Experimental study on effects of intratumoral injection of paclitaxel-loaded poly (lactic-co-glycolic acid) micro-spheres on Hep-2 laryngeal squamous cell carcinoma xenografts in nude mice

Ming XIE,Liang ZHOU,Xiao-lu YIN,Ming YAO

DOI: https://doi.org/10.3781/j.issn.1000-7431.2009.01.002

2009-01-01

Tumor

Abstract:Objective: To investigate the efficacy of intratumoral injection of paclitaxel-loaded poly (lactic-co-glycolic acid) (PLGA) microspheres on Hep-2 laryngeal squamous cell xenografts in nude mice. Methods: The solid tumor model bearing Hep-2 laryngeal squamous cell carcinoma was established in BALB/c nude mice. The model group was given with different therapies. The tumor size and tumor weight were recorded in all of the experimental groups. The tumor inhibition rate (IR) and tumor volume tripling time (TT) were calculated. The counts of microvessel density (MVD), expressions of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) in xenografts were examined by Envision™ immunohistological method. Results: Twenty-one days after treatment, the tumor size and tumor weight of the paclitaxel-treated groups were significantly decreased (P < 0.05) and the TTs were significantly prolonged (P < 0.01) compared with the saline control group. The TT of the group receiving intratumoral injection of paclitaxel PLGA microspheres at a low dose was significantly longer compared with the group receiving intratumoral (i. t.) or intraperitoneal (i. p.) injection of paclitaxel (P <0.05). The TT of the group receiving intratumoral injection of paclitaxel microspheres at a high dose was significantly increased compared with the other paclitaxel-treated groups (P < 0.01). The tumor inhibition rates of paclitaxel intraperitoneal or intratumoral injection groups were 35.99% and 39.37%, respectively; and they were 47.83% and 59.90% for paclitaxel microsphere intratumoral injection groups at low and high doses, respectively. PLGA blank microspheres had no effect on the tumor growth. No significant toxic reactions were observed in the experiment. The counts of MVD and immunoreactivity of bFGF and VEGF in the paclitaxel-treated groups were significantly decreased compared with the saline control group (P < 0.05). The intratumoral injection of paclitaxel microspheres markedly reduced bFGF level and showed stronger anti-angiogenic activity in comparison with i. p. and i. t. administration of paclitaxel injection (P < 0.01). Conclusion: Direct administration of polymeric drug control release system into local tumor bodies had a foreground for the treatment of laryngeal squamous cell carcinoma.